Steven Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host, Thomas McClelland. President and Chief Executive Officer
Thank you, Tom, and good afternoon. For the fiscal year ended April 30, 2025, consolidated revenue was $69.8 million compared to $55.3 million for the same period of the prior fiscal year. The components of revenue are as follows: Revenue from commercial and U.S. government satellite programs was approximately $40.9 million or 59% compared to $23.2 million or 42% in the same period of the prior fiscal year. Revenue on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space U.S. government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments were $26.5 million compared to $29 million in the same period of the prior fiscal year and accounted for approximately 38% of consolidated revenue compared to 52% for the prior fiscal year. Other commercial and industrial revenue was $2.4 million and $3.1 million for the fiscal year ended April 30, '25 and '24, respectively. The company is encouraged by significant revenue growth compared to the prior fiscal year. The majority of the increase in revenue for fiscal year '25 as compared to fiscal year '24 was a result of increase in sales in the U.S. government DoD satellite market. For the fiscal year ending April 30, 2025, the gross profit and gross profit percentage increased as a result of several factors. The increase in gross profit dollars was directly related to the significant increase in revenue over the prior fiscal year period as well as the increase in gross margin. The majority of the increase in the gross profit percentage as compared to the prior fiscal year was in the FEI-New York segment and was attributable to the company's performance on several traditional space programs at higher margin and ahead of schedule. In addition, the company has new programs that are progressing well, and the company anticipates they will generate additional revenue and profits. In the fiscal year ending April 30, '25 and '24, selling and administrative expenses were 18% of consolidated revenue in both periods. While total SG&A expense increased in fiscal year '25 as compared to the prior fiscal year, SG&A expense remained constant as a percentage of revenue in fiscal year '25. The approximately $2.1 million increase is made up of mainly payroll-related items such as 401(k) expense, stock option expense, bonus accrual. In addition to these expenses, trade show and related costs also increased during the fiscal year '25. R&D expense for the fiscal year ending April 30, '25 increased to $6.1 million from $3.4 million, an increase of $2.7 million and were approximately 9% and 6%, respectively, of consolidated revenue. The company-funded R&D amount was higher in fiscal year '25 as compared to previous fiscal year, partially because of the previous fiscal year R&D expenditures were lower than planned and some of the expense were subsequently captured in fiscal year '25. The increase in R&D expense also reflects the company's commitment to maintain its technical excellence. The company expects future R&D investment to be in line with or even potentially above historical spending. For the fiscal year ending April 30, '25, the company recorded operating income of $11.7 million compared to an operating income of $5 million in the prior fiscal year. The increase is mainly attributable to the company's significant increase in revenue and gross margin during fiscal year '25, as noted above from traditional space programs that have been executed ahead of schedule, well within budget and technologically performed well. The positive effect of cost-cutting measures instituted by management have also contributed to the increase. The change in other income expense from prior fiscal year was relatively minimal. All 3 categories presented were slightly lower in fiscal year '25 compared to prior fiscal year. This yields pretax income of approximately $12.1 million compared to $5.5 million for the prior fiscal year. For the fiscal year ending April 30, '25, the valuation allowance decreased by approximately $13.9 million from the prior fiscal year, primarily due to releasing the majority of the valuation allowance recorded against deferred tax asset. This change in estimate occurred in the third quarter of fiscal '25. Consolidated net income for the year ending April 30, '25 was $23.7 million or $2.46 per share compared to $5.6 million or $0.59 per share in the previous fiscal year. Our fully funded backlog at the end of April '25 was approximately $70 million compared to $78 million for the previous fiscal year, April 30, '24. The company's balance sheet continues to reflect strong working capital position of approximately $30 million at April 30, '25, and a current ratio of approximately 2.3:1. Additionally, the company is debt-free. Cash went down by approximately $13.6 million since prior fiscal year-end. Of this decrease, the dividend paid in Q2 of fiscal '25 accounted for approximately $9.6 million of it. The additional $4 million decrease was related to timing of billing and revenue. Contract liabilities went down $8.2 million since year-end. Contract liabilities are generated as part of 606 accounting when the billings are in excess of revenue taken on specific programs. We expect that cash will fluctuate quarter-to-quarter. However, we expect its trend to be higher over time. The company believes that its liquidity is adequate to meet its operating and investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom, and we look forward to your questions shortly.